FDA NDC Directory · JSON-LD · Markdown

Rituxan Hycela

NDC 50242-108 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namerituximab and hyaluronidase
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761064
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsHYALURONIDASE (HUMAN RECOMBINANT) (2000 U/mL)
RITUXIMAB (120 mg/mL)
Marketing started20170622
Package count2

External sources

Source: openFDA. Public-domain (CC0).